Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-05-05

Clinical Trial Update: Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing cefazolin alone versus cefazolin plus azithromycin prophylaxis for post-cesarean endometritis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)
  • CEFAZOLIN (cefazolin sodium)

Snippet

Sponsor: University of Missouri, Kansas City | Conditions: Endometritis | Phase 4 | Status: WITHDRAWN